A feasibility open-label clinical trial utilizing second-generation artificial intelligence based on the constrained-disorder principle in patients with Parkinson's disease
Background: Parkinson's disease (PD) is a neurodegenerative disorder treated with Levodopa, but long-term use often causes motor complications like ''wearing-off,'' ''on-off'' effects, and Levodopa-induced dyskinesias, requiring careful management to balance benefits and risks. The Constrained Disor...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2026-06-01
|
| Col·lecció: | IBRO Neuroscience Reports |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2667242126000369 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|